Font Size: a A A
Keyword [antiangiogenic]
Result: 121 - 140 | Page: 7 of 7
121. Evaluation of rVEGF164b, a novel antiangiogenic VEGF-A isoform, in inflammatory bowel disease: Implications on VEGF-A regulation and potental therapeutic options
122. Characterizing the role of endogenous antiangiogenic factors in neovascular pathology and normal vascular development in the retina
123. The role of angiogenesis in the etiology of ovarian cancer
124. Evaluating breast cancer stem cell response to antiangiogenic therapy
125. Ultrasound-assisted nonviral antiangiogenic small interfering RNA delivery for the treatment of cancer
126. The Functional Study Of CD93 As A New Antiangiogenic Target In Infantile Hemangioma
127. Postoperative Concurrent Chemoradiotherapy Plus Apatinib For First-line Treatment Of Patients With Malignant Glioma
128. PD-1 Inhibitors In Combination With Other Drugs For Advanced Non-small Cell Lung Cancer
129. Study On The Risk Factors Of Tumor-associated Thrombosis And The Influence And Mechanism Of Antiangiogenic Drugs On Tumor-associated Thrombosis
130. Analysis Of Cardio-Cerebrovascular Adverse Events Of Antiangiogenic Drugs In The Treatment Of Brain Metastasis From Lung Cancer
131. Core-satellite Nanosystem For Antiangiogenic And Antivasculogenic Mimicry Therapy
132. Advances In The Treatment Of Advanced Non-small Cell Lung Cancer With Antiangiogenic Drugs Combined With Immune Checkpoint Inhibitors
133. Clinical Efficacy And Safety Of Apatinib Combined With Chemotherapy In The Second-line Treatment Of Small Cell Lung Cancer
134. Construction And Application Of Tumor Microenvironment Responsive Peptide Self-assembled Nano Drugs For Inhibiting Postoperative Recurrence Of Esophageal Squamous Cell Carcinoma
135. Preliminary Study Of HBOC To Increase The Sensitivity Of Lenvatinib In The Treatment Of Hepatocellular Carcinoma Transplanted Tumor Animal Models
136. Clinical Observation Of Immune Checkpoint Inhibitors Plus Antiangiogenic Drugs In Patients With Advanced Hepatocellular Carcinoma
137. Observation Of Clinical Efficacy Of Toripalimab Based Combination Therapy As Second-line In Esophageal Squamous Cell Carcinoma
138. Study Of TKI Antiangiogenic Drugs In The Treatment Of Advanced Breast Cancer
139. Clinical Observation Of Recombinant Human Vascular Endostatin Combined With Chemoradiotherapy In The Treatment Of Locally Advanced Nasopharyngeal Carcinoma
140. A Study On Symptom Cluster And TCM Syndromes Of Intermediate And Advanced Cancer Patients During Antiangiogenic Medication
  <<First  <Prev  Next>  Last>>  Jump to